A new vaccine against Ebola has in a study in Guinea have shown very promising results. According to an article in the medical journal The Lancet the vaccine VSV-ZEBOV provides one hundred percent protection against the disease.
The study, which began in March 2015 has been conducted by Doctors Without Borders, the World Health Organization and the Norwegian Institute of Public Health, FHI in collaboration with the Guinean authorities.
It has focused on people in Ebola patients proximity and the medical staff - a total of 4,000 people have been treated with the vaccine, and none of them have been infected by the disease.
- For the first time ever, we have evidence that a vaccine is effective against Ebola, says Bertrand Draguez, who is leading the efforts to develop new tools in the fight against Ebola.
- The number of people included in the study is admittedly low, and we still need more research and analysis. But the enormous scale of this public health crisis means that we still have to continue using the vaccine to protect those at risk of infection, that is, people in the vicinity of the patients and nursing staff, he says.
More than 10,000 people have died in the latest Ebola epidemic in West Africa. A new vaccine could prevent that such a disaster happened again.
DON'T MISS A POST - FOLLOW US ON FACEBOOK!
Comments at Speisa are unmoderated. We do believe in free speech, but posts using foul language, as well as abusive, hateful, libelous and genocidal posts, will be deleted if seen. However, if a comment remains on the site, it in no way constitutes an endorsement by Speisa of the sentiments contained therein.comments powered by Disqus
280,000 asylum seekers to Germany in just one month
In September alone, nearly 280,000 immigrants made their way to Germany, says the Bavarian Interior Minister, Joachim Herrmann.